Abingdon Health Plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABDX.L research report →
Companywww.abingdonhealth.com
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services.
- CEO
- Christopher William Hand
- IPO
- 2020
- Employees
- 113
- HQ
- York, GB
Price Chart
Valuation
- Market Cap
- $22.52M
- P/E
- -14.17
- P/S
- 2.35
- P/B
- 7.29
- EV/EBITDA
- -6.64
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 34.11%
- Op Margin
- -45.70%
- Net Margin
- -33.88%
- ROE
- -55.91%
- ROIC
- -59.58%
Growth & Income
- Revenue
- $8.43M · 37.39%
- Net Income
- $-3,415,000 · -168.69%
- EPS
- $-0.01 · -121.43%
- Op Income
- $-4,025,000
- FCF YoY
- -101.88%
Performance & Tape
- 52W High
- $13.00
- 52W Low
- $5.10
- 50D MA
- $9.25
- 200D MA
- $7.10
- Beta
- 0.12
- Avg Volume
- 403.39K
Get TickerSpark's AI analysis on ABDX.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ABDX.L Coverage
We haven't published any research on ABDX.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ABDX.L Report →